Ahmedabad-based Zydus Cadila on Wednesday announced that the company has started the supplies of its COVID-19 vaccine ZyCoV-D, to the Government of India against their order from its newly commissioned state of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.
The group is also planning to make the vaccine available in the private market. ZyCoV-D is a three dose vaccine administered intradermally using the painless PharmaJet® needle free system, Tropis®, on day 0, day 28 and day 56. The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST.
ZyCoV-D, received emergency use authorisation (EUA) from the Drugs Controller General of India (DCGI) in August last year, is the only needle-free coronavirus vaccine in the world. It is also the world’s first Plasmid DNA vaccine, and will be administered on days 0, 28 and 56.
The vaccine, which was cleared for the age group of 12 and above, was the first to be granted EUA for an age group below 18. Also, while the inoculation drive began on January 16 last year, teenagers aged 15-18 became eligible for vaccination only on January 3 this year.
